Could an antioxidant pill speed recovery from COPD attacks?
NCT ID NCT07456176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the antioxidant alpha-lipoic acid can help people recover from sudden worsening of COPD (called exacerbations). 75 adults will receive either a low dose (600 mg), a high dose (1200 mg), or a placebo pill for 10 days, alongside standard hospital care. Researchers will measure inflammation, oxygen levels, and how quickly patients get better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Alpha-lipoic acid (an antioxidant) in 600 mg or 1200 mg oral tablets
- What this could lead to
- If it works, this could point toward a simple, low-cost antioxidant supplement to help people recover faster from COPD flare-ups and reduce hospital stays.
- What could go wrong
- This is a small, early-phase trial with only 75 participants, so results may not apply to everyone. The supplement may cause side effects like stomach upset or dizziness, and it might not improve outcomes at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Matareya Teaching Hospital
Cairo, 11856, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.